The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication.
biomarkers
circulating
liver cancer
precision medicine
prognosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
06 Feb 2021
06 Feb 2021
Historique:
received:
26
12
2020
revised:
01
02
2021
accepted:
01
02
2021
entrez:
10
2
2021
pubmed:
11
2
2021
medline:
11
2
2021
Statut:
epublish
Résumé
Showing a steadily increasing cancer-related mortality, the epidemiological evolution of hepatocellular carcinoma (HCC) is concerning. Numerous strategies have attempted to prognosticate HCC but their performance is modest; this is partially due to the heterogeneous biology of this cancer. Current clinical guidelines endorse classifications and scores that use clinical variables, such as the Barcelona Clinic Liver Cancer (BCLC) classification. These algorithms are unlikely to fully recapitulate the genomic complexity of HCC. Integrating molecular readouts on a patient-basis, following a precision-medicine perspective, might be an option to refine prognostic systems. The limited access to HCC tissue samples is an important limitation to these approaches but it could be partially circumvented by using liquid biopsy. This concept consists of the molecular analysis of products derived from a solid tumor and released into biological fluids, mostly into the bloodstream. It offers an easy and minimally-invasive access to DNA, RNA, extracellular vesicles and cells that can be analyzed with next-generation sequencing (NGS) technologies. This review aims to investigate the potential contributions of liquid biopsy in HCC prognostication. The results identified prognostic values for each of the components of liquid biopsy, suggesting that this technology may help refine HCC prognostication.
Identifiants
pubmed: 33562173
pii: cancers13040659
doi: 10.3390/cancers13040659
pmc: PMC7914891
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cancer Lett. 2016 Aug 1;378(1):33-7
pubmed: 27160647
J Hepatol. 2016 Aug;65(2):305-13
pubmed: 27132171
Oncogene. 2018 Jul;37(27):3740-3752
pubmed: 29628508
N Engl J Med. 2004 Aug 19;351(8):781-91
pubmed: 15317891
Cell Mol Gastroenterol Hepatol. 2015 Jun 17;1(5):516-534
pubmed: 28210698
Br J Cancer. 2015 Feb 3;112(3):532-8
pubmed: 25584485
J Cancer Res Clin Oncol. 2009 Aug;135(8):1091-8
pubmed: 19184104
Pharmaceuticals (Basel). 2020 Aug 04;13(8):
pubmed: 32759810
Trends Pharmacol Sci. 2019 Mar;40(3):172-186
pubmed: 30736982
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1317-25
pubmed: 25646427
Eur J Cancer. 2013 Nov;49(16):3442-9
pubmed: 23810247
Lancet Oncol. 2015 Jul;16(7):804-15
pubmed: 26088272
Liver Transpl. 2018 Jul;24(7):946-960
pubmed: 29624843
Hepatology. 2013 Apr;57(4):1458-68
pubmed: 23175471
Liver Int. 2021 Mar;41(3):562-573
pubmed: 33205544
Oncotarget. 2017 Jan 24;8(4):6406-6418
pubmed: 28031532
BMC Cancer. 2019 Apr 1;19(1):292
pubmed: 30935424
Cancer Lett. 2018 Jan 1;412:99-107
pubmed: 29031565
Cancer Discov. 2016 Feb;6(2):147-153
pubmed: 26644315
PLoS One. 2020 Apr 24;15(4):e0232211
pubmed: 32330203
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
Cancer Res. 2008 Aug 15;68(16):6779-88
pubmed: 18701503
Clin Chem. 2019 Jul;65(7):905-915
pubmed: 30996051
Hepatology. 2004 Mar;39(3):792-7
pubmed: 14999698
BMC Cancer. 2020 Oct 31;20(1):1047
pubmed: 33129301
Am J Transplant. 2011 Oct;11(10):2031-5
pubmed: 21831154
Sci Transl Med. 2016 Jul 6;8(346):346ra92
pubmed: 27384348
Sci Rep. 2018 Aug 1;8(1):11570
pubmed: 30068984
Pharmaceuticals (Basel). 2020 Sep 14;13(9):
pubmed: 32937811
J Gastrointest Surg. 2017 Jul;21(7):1112-1120
pubmed: 28378318
J Gastroenterol Hepatol. 2020 Aug 24;:
pubmed: 32830343
Int J Cancer. 2013 Nov;133(9):2165-71
pubmed: 23616258
Semin Liver Dis. 1999;19(3):329-38
pubmed: 10518312
Ann Surg Oncol. 2017 Nov;24(12):3788-3795
pubmed: 28593503
Gastroenterology. 2013 May;144(5):1031-1041.e10
pubmed: 23376424
Medicine (Baltimore). 2019 Aug;98(31):e16557
pubmed: 31374020
Nat Genet. 2014 Dec;46(12):1267-73
pubmed: 25362482
Hepatol Commun. 2018 Apr 27;2(6):718-731
pubmed: 29881823
Nat Med. 2015 Jul;21(7):795-801
pubmed: 26030179
Clin Cancer Res. 2011 Jun 1;17(11):3783-93
pubmed: 21527564
Hepatol Int. 2019 Nov;13(6):726-735
pubmed: 31691073
J Exp Clin Cancer Res. 2018 Jun 26;37(1):124
pubmed: 29941002
Nat Med. 2019 Sep;25(9):1415-1421
pubmed: 31501609
Discov Med. 2015 Apr;19(105):263-73
pubmed: 25977189
N Engl J Med. 2019 Apr 11;380(15):1450-1462
pubmed: 30970190
J Cell Biochem. 2018 Jun;119(6):4711-4716
pubmed: 29278659
Gut. 2008 Nov;57(11):1592-6
pubmed: 18669577
Hepatology. 2020 Nov 25;:
pubmed: 33237575
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
Clin Cancer Res. 2018 Feb 1;24(3):547-559
pubmed: 29070526
PLoS One. 2019 May 29;14(5):e0217586
pubmed: 31141571
Cancer Discov. 2016 Jan;6(1):36-44
pubmed: 26546295
Oncol Lett. 2019 Sep;18(3):3381-3387
pubmed: 31452818
Sci Rep. 2020 Oct 20;10(1):17862
pubmed: 33082400
Ann Surg. 2011 Oct;254(4):569-76
pubmed: 21892074
Neoplasma. 2020 Jul;67(4):909-915
pubmed: 32386482
Tumour Biol. 2015 Jun;36(6):4773-6
pubmed: 25636448
Hepatology. 2015 Jun;61(6):1945-56
pubmed: 25645722
Ann Oncol. 2019 Sep 1;30(9):1472-1478
pubmed: 31250894
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Sci Rep. 2019 Jul 18;9(1):10464
pubmed: 31320713
Oncotarget. 2016 Jun 28;7(26):40481-40490
pubmed: 27248174
Int J Cancer. 2019 Mar 15;144(6):1444-1452
pubmed: 30338850
Mol Cancer. 2017 Oct 13;16(1):159
pubmed: 29029605
Surg Oncol. 2020 Jun;33:276-281
pubmed: 32561093
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
World J Gastroenterol. 2004 Mar 1;10(5):643-8
pubmed: 14991930
Oncotarget. 2017 Sep 14;8(46):80666-80678
pubmed: 29113334
Oncotarget. 2017 Sep 23;8(52):89978-89987
pubmed: 29163804
N Engl J Med. 2008 Nov 6;359(19):1995-2004
pubmed: 18923165
Nat Genet. 2015 May;47(5):505-511
pubmed: 25822088
Clin Cancer Res. 2018 May 1;24(9):2203-2213
pubmed: 29374055
Scand J Gastroenterol. 2020 Dec;55(12):1433-1440
pubmed: 33103505
Nat Commun. 2020 Jan 15;11(1):291
pubmed: 31941899
Free Radic Res. 2018 Apr;52(4):455-464
pubmed: 29463155
Gut. 2020 Nov;69(11):2025-2034
pubmed: 32883873
Hepatol Commun. 2020 Aug 04;4(10):1527-1540
pubmed: 33024921
PLoS One. 2020 Sep 22;15(9):e0239386
pubmed: 32960907
Cancer Res. 2018 Aug 15;78(16):4731-4744
pubmed: 29915159
Oncotarget. 2016 Jan 19;7(3):2646-59
pubmed: 26544731
Hepatology. 2018 Jan;67(1):358-380
pubmed: 28130846
Gastroenterology. 2011 May;140(5):1501-12.e2
pubmed: 21320499
Clin Cancer Res. 2019 Sep 1;25(17):5284-5294
pubmed: 31217202
Surg Today. 2005;35(12):1033-41
pubmed: 16341483
Exp Mol Pathol. 2011 Dec;91(3):702-7
pubmed: 21884695
Int J Cancer. 2016 Jan 1;138(1):206-16
pubmed: 26178530
JAMA Oncol. 2019 Oct 17;:
pubmed: 31621801
Cell. 2020 Aug 20;182(4):1044-1061.e18
pubmed: 32795414
Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):181-189
pubmed: 27839726
BMC Cancer. 2018 Aug 20;18(1):835
pubmed: 30126375
Cancer Res. 2008 Mar 1;68(5):1451-61
pubmed: 18316609
Hepatoma Res. 2017;3:105-111
pubmed: 28795155
Hepatology. 2011 Mar;53(3):1020-2
pubmed: 21374666
Cytometry A. 2015 Nov;87(11):1020-8
pubmed: 26355643
Ann Transl Med. 2020 Sep;8(17):1067
pubmed: 33145286
Liver Int. 2020 Nov;40(11):2834-2847
pubmed: 32594568
PLoS One. 2013 Nov 14;8(11):e80053
pubmed: 24244607
Clin Transl Med. 2020 Jul;10(3):e137
pubmed: 32702202
Medicine (Baltimore). 2020 Oct 2;99(40):e22242
pubmed: 33019399
Nat Mater. 2017 Nov;16(11):1155-1161
pubmed: 29035356
Clin Cancer Res. 2014 Sep 15;20(18):4794-805
pubmed: 25009297
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394
J Int Med Res. 2020 Apr;48(4):300060519896144
pubmed: 32339037
Oncogene. 2021 Jan;40(1):140-151
pubmed: 33097857